Endovascular therapy versus best medical treatment in pediatric acute ischemic stroke: A systematic review and meta-analysis
Lucca Tamara Alves Carretta, Mariana Letícia de Bastos Maximiano, Rudolfh Batista Arend, Rafael Torres Fonseca dos Santos, Mariana Lee Han, Bruna Lara Zardin, Ocilio de Deus, Anderson Silva Corin, Nicole Baptista de Oliveira, Marianna Leite, Pedro Torezani Colodetti, Fernando Rocha Oliveira, Tassiane Cristina Morais, Leandro de Assis Barbosa, Ahmet GünkanPurpose
This systematic review and meta-analysis evaluates endovascular therapy (EVT) versus best medical treatment (BMT) in pediatric acute ischemic stroke (AIS) due to large-vessel occlusion.
Methods
Systematic searches were conducted across PubMed, Cochrane, and Embase, inception July-2025. Comparative studies of EVT versus BMT in pediatric AIS were included. Efficacy outcomes assessed were Modified Rankin Scale (mRS) 0–2, mRS 0–1 and Pediatric Stroke Outcome Measure (PSOM). Safety outcomes included mortality, symptomatic intracranial hemorrhage (sICH), any intracranial hemorrhage (aICH), hospital stay length and need for craniectomy.
Results
10 studies (
Conclusion
When restricted to confirmed LVO, EVT demonstrates a potential functional benefit over BMT in pediatric AIS. The increased risks of aICH and mortality observed in broader analyses are likely confounded by indication, reflecting the selection of the most severe cases for intervention. Based on GRADE assessments, the certainty of evidence remains very low, highlighting the critical need for prospective studies incorporating standardized reperfusion metrics.